We have been asked by a number of parties for incremental commentary regarding the recent news out of Pathfinder and also the research we produced per HERE.

Our position is as follows – We have made exceptionally clear to management that the time for closure on this issue is now, that there is no room for largesse on salaries, Plc peripheral costs etc and these have been taken on board. Our participation in the debt and warrant raise was contingent upon this and the expectation that the monies be applied to close a deal that works for all. Indeed, we headed off what in the alternate would have been a likely discounted placing – such is our belief in the asset claims worth.

We are also aware that there are certain quarters in the City that, out of malice, spite or the sheer absence of human morality have been casting doubt on the progress detailed in the Company’s RNS per HERE.

This is not a normal statement to be made by us but we do not want innocent shareholders that have followed our research and taken solace in our putting our money where our mouth is – running to decent hundreds of thousands – now being scaremongered by such machiavelli forces when it appears we are sitting at the endgame. Trust us, this game is full of such characters.

Our Tr1 release today illustrates succinctly what we believe is up for grabs – a resolution that we believe is worth many multiples of the current stock price which, at 0.7p remains valued as a mere shell. Shareholders should again listen closely to the interview we carried out HERE.

RISK WARNING & DISCLAIMER

Pathfinder is a research client of Align Research. Align Research and a director of Align Research own shares in Pathfinder and are bound to the company’s dealing policy ensuring open and adequate disclosure. Full details can be found on our website here (“Legals”).

This is a marketing communication and cannot be considered independent research. Nothing in this report should be construed as advice, an offer, or the solicitation of an offer to buy or sell securities by us. As we have no knowledge of your individual situation and circumstances the investment(s) covered may not be suitable for you. You should not make any investment decision without consulting a fully qualified financial advisor.

Your capital is at risk by investing in securities and the income from them may fluctuate. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. The marketability of some of the companies we cover is limited and you may have difficulty buying or selling in volume. Additionally, given the smaller capitalisation bias of our coverage, the companies we cover should be considered as high risk.

This financial promotion has been approved by Align Research Limited

• Pathfinder Minerals